Literature DB >> 27754893

Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion.

Wendy V Norman1, Judith A Soon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27754893      PMCID： PMC5135516          DOI： 10.1503/cmaj.160581

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Clinical practice. A request for abortion.

Authors:  Allan Templeton; David A Grimes
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

2.  Mifepristone by prescription: a dream in the United States but reality in Australia.

Authors:  Daniel Grossman; Philip Goldstone
Journal:  Contraception       Date:  2015-06-19       Impact factor: 3.375

3.  RU486: the French experience.

Authors:  A Ulmann; L Silvestre
Journal:  Hum Reprod       Date:  1994-06       Impact factor: 6.918

4.  Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Authors:  Mette Løkeland; Ole Erik Iversen; Anders Engeland; Ingrid Økland; Line Bjørge
Journal:  Acta Obstet Gynecol Scand       Date:  2014-05-23       Impact factor: 3.636

5.  Medical Abortion.

Authors:  Dustin Costescu; Edith Guilbert; Jeanne Bernardin; Amanda Black; Sheila Dunn; Brian Fitzsimmons; Wendy V Norman; Helen Pymar; Judith Soon; Konia Trouton; Marie-Soleil Wagner; Ellen Wiebe; Karen Gold; Marie-Ève Murray; Beverly Winikoff; Matthew Reeves
Journal:  J Obstet Gynaecol Can       Date:  2016-04-23
  5 in total
  7 in total

1.  Abortion services and providers in Canada in 2019: results of a national survey.

Authors:  Regina M Renner; Madeleine Ennis; Damien Contandriopoulos; Edith Guilbert; Sheila Dunn; Janusz Kaczorowski; Elizabeth K Darling; Arianne Albert; Claire Styffe; Wendy V Norman
Journal:  CMAJ Open       Date:  2022-09-27

2.  Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study.

Authors:  Sarah Munro; Edith Guilbert; Marie-Soleil Wagner; Elizabeth S Wilcox; Courtney Devane; Sheila Dunn; Melissa Brooks; Judith A Soon; Megan Mills; Genevieve Leduc-Robert; Kate Wahl; Erik Zannier; Wendy V Norman
Journal:  Ann Fam Med       Date:  2020-09       Impact factor: 5.166

3.  Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing.

Authors:  Nevena Rebic; Sarah Munro; Wendy V Norman; Judith A Soon
Journal:  Can Pharm J (Ott)       Date:  2021-05-28

4.  Leadership for success in transforming medical abortion policy in Canada.

Authors:  Brigid Dineley; Sarah Munro; Wendy V Norman
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

5.  Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.

Authors:  Courtney Devane; Regina M Renner; Sarah Munro; Édith Guilbert; Sheila Dunn; Marie-Soleil Wagner; Wendy V Norman
Journal:  Pilot Feasibility Stud       Date:  2019-11-08

6.  Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.

Authors:  Enav Z Zusman; Sarah Munro; Wendy V Norman; Judith A Soon
Journal:  BMJ Open       Date:  2022-10-07       Impact factor: 3.006

7.  Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation.

Authors:  Sarah Munro; Kate Wahl; Judith A Soon; Edith Guilbert; Elizabeth S Wilcox; Genevieve Leduc-Robert; Nadra Ansari; Courtney Devane; Wendy V Norman
Journal:  Implement Sci       Date:  2021-08-03       Impact factor: 7.327
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.